A detailed history of Royce & Associates LP transactions in Apyx Medical Corp stock. As of the latest transaction made, Royce & Associates LP holds 2,436,659 shares of APYX stock, worth $3.27 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,436,659
Previous 2,158,900 12.87%
Holding current value
$3.27 Million
Previous $5.66 Million 41.43%
% of portfolio
0.03%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.25 - $2.71 $347,198 - $752,726
277,759 Added 12.87%
2,436,659 $3.31 Million
Q4 2023

Feb 12, 2024

BUY
$1.49 - $3.25 $222,457 - $485,225
149,300 Added 7.43%
2,158,900 $5.66 Million
Q3 2023

Nov 09, 2023

BUY
$3.07 - $6.2 $1.25 Million - $2.52 Million
406,624 Added 25.37%
2,009,600 $6.43 Million
Q2 2023

Aug 07, 2023

BUY
$2.75 - $7.59 $400,837 - $1.11 Million
145,759 Added 10.0%
1,602,976 $8.06 Million
Q1 2023

May 04, 2023

BUY
$2.45 - $3.59 $1.61 Million - $2.36 Million
658,749 Added 82.5%
1,457,217 $4.2 Million
Q4 2022

May 23, 2023

SELL
$1.4 - $5.02 $922,248 - $3.31 Million
-658,749 Reduced 45.21%
798,468 $1.87 Million
Q4 2022

Feb 13, 2023

SELL
$1.4 - $5.02 $120,119 - $430,715
-85,800 Reduced 9.7%
798,468 $1.87 Million
Q3 2022

Nov 03, 2022

BUY
$4.8 - $10.83 $1.99 Million - $4.49 Million
415,000 Added 88.44%
884,268 $3.97 Million
Q2 2022

Aug 04, 2022

BUY
$3.11 - $7.5 $21,148 - $51,000
6,800 Added 1.47%
469,268 $2.75 Million
Q1 2022

May 05, 2022

SELL
$5.87 - $13.13 $68,092 - $152,308
-11,600 Reduced 2.45%
462,468 $3.02 Million
Q4 2021

Feb 07, 2022

SELL
$12.15 - $17.4 $847,243 - $1.21 Million
-69,732 Reduced 12.82%
474,068 $6.08 Million
Q3 2021

Nov 10, 2021

SELL
$8.79 - $13.96 $131,850 - $209,400
-15,000 Reduced 2.68%
543,800 $7.53 Million
Q3 2020

Nov 12, 2020

BUY
$4.38 - $5.47 $897,462 - $1.12 Million
204,900 Added 57.9%
558,800 $2.63 Million
Q2 2020

Aug 07, 2020

SELL
$2.87 - $5.83 $106,565 - $216,473
-37,131 Reduced 9.5%
353,900 $1.96 Million
Q1 2020

May 12, 2020

SELL
$3.24 - $8.51 $391,340 - $1.03 Million
-120,784 Reduced 23.6%
391,031 $1.4 Million
Q4 2019

Feb 06, 2020

BUY
$6.29 - $8.46 $288,711 - $388,314
45,900 Added 9.85%
511,815 $4.33 Million
Q3 2019

Nov 13, 2019

BUY
$6.3 - $7.9 $714,420 - $895,860
113,400 Added 32.17%
465,915 $3.15 Million
Q2 2019

Aug 12, 2019

SELL
$3.64 - $6.95 $1.47 Million - $2.8 Million
-402,900 Reduced 53.33%
352,515 $2.37 Million
Q1 2019

May 09, 2019

BUY
$6.31 - $8.75 $4.77 Million - $6.61 Million
755,415 New
755,415 $4.77 Million

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $46.3M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.